Moving forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories.

Authors

Ritu Nayar
David C Chhieng
Barbara Crothers
Teresa M Darragh
Diane D Davey
Carol Eisenhut
Robert Goulart
Eric C Huang
Sana O. Tabbara, George Washington University

Document Type

Journal Article

Publication Date

5-23-2020

Journal

Journal of the American Society of Cytopathology

DOI

10.1016/j.jasc.2020.05.002

Comments

Online ahead of print

APA Citation

Nayar, R., Chhieng, D., Crothers, B., Darragh, T., Davey, D., Eisenhut, C., Goulart, R., Huang, E., & Tabbara, S. O. (2020). Moving forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories.. Journal of the American Society of Cytopathology, (). http://dx.doi.org/10.1016/j.jasc.2020.05.002